The Journal of Chemical PhysicsBiochemistryPeer-reviewed journal article
Physical-Chemical Approach to Identify Local Structural Determinants of Molecular Mechanisms: Case Study of Antimalarial Drug Pyronaridine and Crystal-Growth Inhibition
Angela MedvedevaiD, Ksenia Kolomeisky, Anatoly B. KolomeiskyiD
Abstract
Understanding how specific molecular substructures control chemical behavior is central to rational molecular design and the development of new materials. However, most current predictive models offer limited mechanistic resolution at the fragmental level. We present a novel physical-chemical computational framework, which is based on systematically perturbing a parent molecule, to quantify fragment-level contributions to both a specific mechanistic action and a broader functional outcome. To test our theoretical approach, we investigated local structural contributions to pyronaridine (PY), a clinically used antimalarial drug with a mechanistically distinctive mode of inhibition of hematin crystal growth via step-bunching. Chemically plausible PY molecular analogs have been computationally generated by selectively removing or substituting functional groups hypothesized to influence either step-bunching mechanisms or whole-parasite blood-stage activity. For each analog, we predicted the probability of four different crystal-growth inhibition mechanisms using a centroid-based similarity model based on a small dataset of experimentally verified crystal-growth inhibitors. The blood-stage antimalarial activity has also been estimated using the MAIP platform. A systematic comparison of molecular analogs revealed that step-bunching mechanisms depend primarily on two protonated pyrrolidines, with chlorobenzene as a strong secondary contributor. In contrast, antimalarial activity is more distributed, relying on coordinated interactions between aromatic-heteroatom scaffolds and an amine linker. The obtained results demonstrate that our approach can disentangle position-specific and cooperative fragmental effects, offering mechanistically interpretable guidance for the design of mechanism-optimized inhibitors. The framework might be broadly applicable across chemical and materials domains where linking local structure to specific mechanisms is essential.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 7th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Aryl N-acetamide compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1.
Coralie Boulet, Joyanta K. Modak, … Paul R. Gilson·bioRxiv·Mar 18, 2025
- Structural basis for multiple binding modes of antimalarial ligands targeting Plasmodium falciparum NCR1
Aaron Kohling, Coralie Boulet, … Volodymyr M. Korkhov·bioRxiv·Nov 11, 2025
- Optimisation-based modelling for drug discovery in malaria
Yutong Li, Jonathan Cardoso‐Silva, … Sophia Tsoka·bioRxiv·Feb 12, 2022
- Xanthine urolithiasis: Inhibitors of xanthine crystallization
F. Grases, A. Costa-Bauza, … A. Rodriguez·bioRxiv·May 31, 2018
- Exploring heteroaromatic rings as a replacement for the labile amide of antiplasmodial pantothenamides
J. Guan, C. Spry, … K. Auclair·bioRxiv·Oct 2, 2020
- Thiazole substitution of a labile amide bond - a new option towards stable pantothenamide-mimics
Xiangning Liu, Annica Chu, … Kevin J. Saliba·bioRxiv·Feb 25, 2025